Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0412 per EA under NDC 59746027910. Its NADAC has been published 81 times since May 15, 2024.
FDA first approved this application on Sep 12, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746027910
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA202280FDA Approved
9/12/2012
TE Code
AB
On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 81 times since May 15, 2024, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0412 per EA |
|---|---|
| All-time high | $0.0474 (Jul 16, 2025) |
| All-time low | $0.0328 (Nov 20, 2024) |
| 52-week high | $0.0439 |
| 52-week low | $0.0412 |
| Median price | $0.0451 |
| Average price | $0.0429 |
| Largest weekly change | -27.3% (Nov 20, 2024) |
| Weeks tracked | 81 |
| Tracking since | May 15, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-6.2%
3Y
N/A
5Y
N/A
All
+4.7%
Last surveyed Nov 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Jubilant Cadista Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Escitalopram Oxalate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0412 per EA (NDC 59746027910), effective Nov 26, 2025.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has risen 4.7%. It has been tracked across 81 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since May 15, 2024, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.0474 (Jul 16, 2025), with a median of $0.0451 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ESCITALOPRAM 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 59746027910) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.